Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest MDS Inc. Stories

2012-05-22 02:26:22

INDIANAPOLIS, May 22, 2012 /PRNewswire/ -- Prosolia, Inc. and AB SCIEX announced today that they have entered into a license agreement for technologies developed by Dr. Gary Van Berkel and his colleagues of Oak Ridge National Laboratory (ORNL). Dr. Van Berkel is an innovator in the field of mass spectrometry and is the recipient of several awards for his contributions in the field. The agreement provides Prosolia a license to a portfolio of new sample introduction and ionization methods...

2012-05-09 02:27:26

AUSTIN, Texas, May 9, 2012 /PRNewswire/ -- e-MDs, a leading provider of electronic health records (EHRs), is proud to announce another year of increased revenue and continued employee growth. Over the past year, e-MDs increased revenues by over 20% and their employee count by 10%. Since 2007, the company has experienced an average increase in annual revenue of more than 20%. e-MDs was profitable in 2011 and maintained substantial cash reserves despite investing nearly 40% of its annual...

2012-03-06 15:56:00

OTTAWA, March 6, 2012 /PRNewswire/ - The Board of Directors for Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today declared a quarterly dividend of US$0.10 per share on the outstanding common shares of the Company. The dividend is payable on April 5, 2012 to shareholders of record at the close of business on March 21, 2012. About Nordion Inc. Nordion Inc. (TSX: NDN) (NYSE: NDZ) is a global health science...

2011-03-09 18:24:00

First quarter financial results demonstrate stability for Nordion Highlights: -- Extended sales contract with major customer Lantheus Medical Imaging until 2013 -- Announced return of cash to shareholders through dividend and Normal Course Issuer Bid (NCIB) -- Achieved cost savings following completion of strategic repositioning Nordion reports in U.S. dollars unless otherwise specified OTTAWA, March 9...

2010-10-26 07:00:00

OTTAWA, Oct. 26 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global health science market, today announced it will be formally changing its name to Nordion Inc., effective November 1, 2010. The Company name change was approved by a shareholder vote on March 11, 2010 at the Special Annual Shareholders Meeting. In line with the name change to Nordion Inc., the corresponding ticker symbols under which the Company trades on...

2010-10-15 07:00:00

Strong Corporate Values, Employee Engagement and Contributions to the Community Make the Company an Exciting Place to Work OTTAWA, Oct. 15 /PRNewswire/ - For the second straight year, MDS Nordion, a leading provider of products and services to the global health science market, has been named one of Canada's Top 100 Employers by Mediacorp Canada, the nation's largest publisher of employment-related periodicals and online directories. "MDS Nordion's employees are the company's greatest...

2010-09-23 05:00:00

OTTAWA, Sept. 23 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global health science market, today announced it has entered into a framework agreement with The Open Joint Stock Company "Isotope" (Isotope), the authorized subsidiary of Rosatom State Corporation, to explore and define areas of collaboration in the field of supply, marketing and sale of isotopes produced in Russia. Conference Call The Company will host an analyst...

2010-09-23 05:00:00

MDS Nordion secures exclusive Mo-99 supply through framework agreement OTTAWA, Sept. 23/> /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of products and services to the global health science market, today announced it has entered into a framework agreement with The Open Joint Stock Company "Isotope" (Isotope), the authorized subsidiary of Rosatom State Corporation, to explore and define areas of collaboration in the field of supply, marketing and sale of isotopes produced in...

2010-09-14 18:00:00

Solid preparations position MDS Inc. well for restart of reactor-based medical isotope production Highlights: - Signed a molybdenum-99 (Mo-99) supply agreement with a major customer to provide medical isotopes to the global nuclear medicine community - On track to substantially complete transition and restructuring activities by the end of fiscal 2010 - Maintained a solid cash position to support ongoing operations and obligations OTTAWA, Sept. 14 /PRNewswire-FirstCall/ - MDS Inc. (TSX:...

2010-09-03 07:00:00

OTTAWA, Sept. 3 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global health science market, today announced that the Company will report its third quarter 2010 financial results after market hours on September 14, 2010. Third Quarter 2010 Conference Call The Company will also host an analyst conference call with Steve West, Chief Executive Officer and Peter Dans, Senior Vice-President and Chief Financial Officer, to discuss the...